Swiss global healthcare firm Roche has decided to invest CHF450m ($467m) in developing a new diagnostic manufacturing plant in Suzhou, China.

The investment will be made in the next three years to build the facility, which is expected to meet the growing demand for diagnostic tests in China and the Asia Pacific region.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

A new Chinese facility will concentrate on producing immunochemistry and clinical chemistry tests, as well as products crucial to clinical laboratory testing.

According to the company, the site plans to build a workforce of more than 600 employees over the next few years.

“The new Chinese facility will concentrate on manufacturing immunochemistry and clinical chemistry tests, as well as products crucial to clinical laboratory testing.”

Roche Diagnostics chief operating officer Roland Diggelmann said: “Roche is committed to investing in China and the Asia Pacific region.

“The new site will enable us to meet the growing demand for our diagnostic products, ensuring our continuous contribution to the health of people in China and the Asia Pacific region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are confident that by establishing our manufacturing footprint here in Suzhou close to our China operations, we can further increase our market responsiveness and contribute to the overall competitiveness of our business.”

The new Roche Diagnostics production facility is scheduled to be fully operational by 2018 and will initially focus on packaging operations in the first phase.

According to the company, the new facility will be the eighth worldwide and the first in the Asia Pacific region.

Roche Diagnostics is focused on providing new tests and technologies to labs and hospitals worldwide.